Isolation of ORCTL3 in a novel genetic screen for tumor-specific apoptosis inducers

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Targeting cancer-specific vulnerabilities is crucial for effective tumor therapy.
• Identifying genes that selectively induce apoptosis in cancer cells is a key research area.
• The organic cation transporter gene family's role in cell death pathways is not fully understood.

Purpose of the Study:

• To establish a high-throughput screening method for identifying genes inducing selective tumor cell death.
• To identify novel genes that trigger apoptosis in transformed cells but not normal cells.
• To elucidate the mechanism by which ORCTL3 induces apoptosis and its relevance in human cancers.

Main Methods:

• Systematic high-throughput screening for apoptosis-inducing genes in transformed cell lines.
• Synthetic lethal screening comparing normal versus oncogene-transformed isogenic cells.
• Investigating the mechanism of ORCTL3-induced apoptosis, including endoplasmic reticulum stress pathways.

Main Results:

• The organic cation transporter-like 3 (ORCTL3) gene was identified as inducing apoptosis specifically in oncogene-transformed cells (e.g., H-ras, v-src).
• ORCTL3 induces cell death independently of its transporter activity, primarily via endoplasmic reticulum stress.
• ORCTL3 expression was found to be downregulated in human kidney tumors, suggesting a tumor suppressor role.

Conclusions:

• ORCTL3 is a novel tumor-selective apoptosis inducer, acting through endoplasmic reticulum stress.
• ORCTL3 represents a potential therapeutic target for various cancers.
• Downregulation of ORCTL3 in kidney tumors highlights its potential role in tumorigenesis.